Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01137513 · ClinicalTrials.gov registry record

T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome

A clinical trial, sponsored by Loma Linda University.

Completed
Registry status
252
Enrollment target

NCT01137513 is a clinical trial that has completed, run by Loma Linda University. The registered enrollment target is 252 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01137513 has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
252 participants
Enrollment target

Study Summary

The purpose of this study is to measure T-Wave Alternans (TWA) in patients with acute coronary syndrome. Researchers are blinded to clinical TWA measurements. The investigators will then try to determine if T-Wave alternans correlates with clinical outcome of patients with Acute Coronary Syndrome. During routine care of the patient, the T Wave Alternans is measured.

Interventions

  • DEVICE Observational Measurement of T-wave Alternans
  • DEVICE T-wave Alternans

Trial Details

FieldValue
Enrollment Target 252 participants
Start Date 2010-07
Est. Completion 2013-12

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT01137513

The ClinicalTrials.gov registry entry for NCT01137513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Observational Measurement of T-wave Alternans is the first listed.

NCT01137513 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01137513 about?

NCT01137513 is a clinical study titled "T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome". The purpose of this study is to measure T-Wave Alternans (TWA) in patients with acute coronary syndrome. Researchers are blinded to clinical TWA measurements. The investigators will then try to determine if T-Wave alternans correlates with clinical outcome of patients with Acute Coronary Syndrome. D...

What is the current status of trial NCT01137513?

This trial is currently completed. The enrollment target is 252 participants. The study started on 2010-07. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01137513?

The interventions under investigation include: Observational Measurement of T-wave Alternans (DEVICE), T-wave Alternans (DEVICE).

Who is sponsoring clinical trial NCT01137513?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.